✦ LIBER ✦

Pharmacokinetic Sub-Study in the SPIRIT III Randomized and Controlled Trial of XIENCE V® Everolimus Eluting Coronary Stent System

✍ Scribed by QING WANG; WESLEY PIERSON; POORNIMA SOOD; CORNELIS BOL; LOUIS CANNON; PAUL GORDON; JORGE SAUCEDO; KRISHNANKUTTY SUDHIR

Book ID: 109216962
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 190 KB
Volume: 23
Category: Article
ISSN: 0896-4327
DOI: 10.1111/j.1540-8183.2009.00517.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gender-based evaluation of the XIENCE V™

Gender-based evaluation of the XIENCE V™ everolimus-eluting coronary stent system: : Clinical and angiographic results from the spirit III randomized trial

✍ Alexandra J. Lansky; Vivian G. Ng; Halil Mutlu; Ecaterina Cristea; Julian Beneta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

The XIENCE nano™ everolimus eluting coro

The XIENCE nano™ everolimus eluting coronary stent system for the treatment of small coronary arteries: The SPIRIT small vessel trial

✍ Louis A. Cannon; Daniel I. Simon; Dean Kereiakes; Jennifer Jones; Roxana Mehran; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB

Outcomes in Diabetic and Nondiabetic Pat

Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents: Results From the SPIRIT IV Clinical Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)

✍ Dean J. Kereiakes; Donald E. Cutlip; Robert J. Applegate; John Wang; Manejeh Yaq 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

TCT-364: Side-Branch Occlusion with XIEN

TCT-364: Side-Branch Occlusion with XIENCE V Everolimus-eluting and TAXUS EXPRESS2 Paclitaxel-eluting Stents: 2-Year Results from the SPIRIT III Randomized Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 201 KB

The SPIRIT V Diabetic Study: A randomize

The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions

✍ Eberhard Grube; Bernard Chevalier; Giulio Guagliumi; Peter C. Smits; Marrianne S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 603 KB